Radioimmuno-tracing of metastatic lymph node for gastric cancer: status quo and progress.
- Author:
Yunyun PAN
1
;
Hao WANG
;
Min FENG
;
Wenxian GUAN
Author Information
1. Department of General Surgery, Nanjing Drum Tower Hospital, The Clinical College of Nanjing Medical University, Nanjing 210000, China. Guan-wx@163.com.
- Publication Type:Journal Article
- MeSH:
Antibodies, Monoclonal;
Disease Progression;
Humans;
Lymph Nodes;
Lymphatic Metastasis;
Neoplasm Staging;
Prognosis;
Stomach Neoplasms
- From:
Chinese Journal of Gastrointestinal Surgery
2015;18(3):298-300
- CountryChina
- Language:Chinese
-
Abstract:
Lymph node metastasis is one of the factors associated with the prognosis of gastric cancer patients. While precise evaluation of nodal status can promote the personalized surgery and improve prognosis. Although with many unsolved problems and limitations, radioimmune technique can be used to trace gastric cancer and metastatic lymph nodes. With the constant development of monoclonal antibody, genetic engineering antibody, nuclide molecular functional imaging, the radioimmune technique may allow tumor targeting, preoperative imaging, and intraoperative tracing. Therefore, more accurate tumor staging and optimal therapeutic regimen may be possible. This review mainly focuses on the utility of radioimmuno-tracing technique in metastatic lymph node for gastric cancer.
